Target intelligence / Profile preview

RNA, U6 small nuclear 340, pseudogene (RNU6-340P)

Target
RNU6-340P
Molecular classification
Other (pseudogene), Small nuclear RNA-derived pseudogene
01

Overview

"RNA, U6 small nuclear 340, pseudogene" (RNU6-340P) is a **pseudogene derived from the U6 small nuclear RNA (snRNA)** gene family. U6 snRNA is an essential, highly conserved noncoding RNA component of the spliceosome, the major nuclear complex responsible for excising introns during pre-mRNA splicing in eukaryotes[3][1]. However, as a **pseudogene**, RNU6-340P is a **non-functional, duplicated genomic copy** of the parental U6 gene that has lost the ability to code for a functional RNA molecule due to accumulated mutations or truncations[2][5]. Such snRNA pseudogenes are common in vertebrate genomes, often generated by **retrotransposition mechanisms** (such as LINE-1-mediated events) and reflect the evolutionary mobility of small nuclear RNA genes[2]. Pseudogenes like RNU6-340P are not known to act as enzymes, receptors, or active molecular targets, nor are they directly involved in disease processes or targeted by drugs[2][3]. **Key points:** - This entry is a **pseudogene**, not an active gene or molecular target. - It does not encode a protein, enzyme, receptor, or regulatory RNA product[2][3][5]. - No known biological functions, disease roles, or drug interactions are associated with this pseudogene. - Its nomenclature "340" refers to its annotation as the 340th U6 pseudogene in the human genome. **Notable issues:** - This is not a valid therapeutic target; it is a **non-functional genomic element**. - Entries for functional spliceosome-related U6 snRNA should instead refer to the canonical "U6 small nuclear RNA" (RNU6-1 or RNU6), which is essential for splicing, but not this pseudogene[1][3].

Other names
RNU6-340PU6 pseudogene 340RNA, U6 small nuclear 340 pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 340, pseudogene (RNU6-340P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 340, pseudogene (RNU6-340P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call